By Emily Field ( July 29, 2021, 6:09 PM EDT) -- Novartis Pharmaceuticals Inc. told the Judicial Panel on Multidistrict Litigation on Thursday that suits alleging its blood cancer drug Tasigna causes cardiovascular disease should not be consolidated, since the company believes it is unlikely that significantly more suits will be filed in federal court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.